[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At …
introduced in the United Kingdom to accelerate population coverage with a single dose. At …
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production
Extracellular adenosine is elevated in cancer tissue, and it negatively regulates local
immune responses. Adenosine production from extracellular ATP has attracted attention as …
immune responses. Adenosine production from extracellular ATP has attracted attention as …
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
A Shields, SE Faustini, M Perez-Toledo, S Jossi… - Thorax, 2020 - thorax.bmj.com
Objective To determine the rates of asymptomatic viral carriage and seroprevalence of
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of …
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of …
Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia …
MM Fretz, NA Penning, S Al-Taei, S Futaki… - Biochemical …, 2007 - portlandpress.com
Delineating the mechanisms by which cell-penetrating peptides, such as HIV-Tat peptide,
oligoarginines and penetratin, gain access to cells has recently received intense scrutiny …
oligoarginines and penetratin, gain access to cells has recently received intense scrutiny …
Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
Exosomes are a distinct population of extracellular vesicles of endocytic origin with a protein
repertoire similar to the parent cell. Although tumour-derived exosomes harbour …
repertoire similar to the parent cell. Although tumour-derived exosomes harbour …
Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors
S Al-Taei, NA Penning, JC Simpson… - Bioconjugate …, 2006 - ACS Publications
Transduction domains such as those derived from the HIV-TAT protein are candidate vectors
for intracellular delivery of therapeutic macromolecules such as DNA and proteins. The …
for intracellular delivery of therapeutic macromolecules such as DNA and proteins. The …
[PDF][PDF] COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
B cell chronic lymphocytic leukemia (CLL) is the most common subtype of adult leukemia
and is associated with profound secondary immunodeficiency. SARS-CoV-2 infection has …
and is associated with profound secondary immunodeficiency. SARS-CoV-2 infection has …
[PDF][PDF] Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV–TAT peptide …
M Fretz, J Jin, R Conibere, NA Penning… - Journal of Controlled …, 2006 - Elsevier
Protein transduction domains such as those derived from the HIV protein TAT have great
potential as vectors for delivery of therapeutic entities such as genes and proteins into cells …
potential as vectors for delivery of therapeutic entities such as genes and proteins into cells …
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody …
AM Shields, SE Faustini… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Objective To determine clinical and ethnodemographic correlates of serological responses
against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. Design A …
against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. Design A …